載入...
Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance
BACKGROUND: Advanced prostate cancer is currently treated with androgen deprivation therapy (ADT). ADT initially results in tumor regression, however, all patients eventually relapse with castration-resistant prostate cancer. New approaches to delay the progression of prostate cancer to castration r...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3319476/ https://ncbi.nlm.nih.gov/pubmed/22161776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22458 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|